7 research outputs found

    Preliminary design of a supersonic Short Takeoff and Vertical Landing (STOVL) fighter aircraft

    Get PDF
    The preliminary design study of a supersonic Short Takeoff and Vertical Landing (STOVL) fighter is presented. A brief historical survey of powered lift vehicles was presented, followed by a technology assessment of the latest supersonic STOVL engine cycles under consideration by industry and government in the U.S. and UK. A survey of operational fighter/attack aircraft and the modern battlefield scenario were completed to develop, respectively, the performance requirements and mission profiles for the study. Three configurations were initially investigated with the following engine cycles: a hybrid fan vectored thrust cycle, a lift+lift/cruise cycle, and a mixed flow vectored thrust cycle. The lift+lift/cruise aircraft configuration was selected for detailed design work which consisted of: (1) a material selection and structural layout, including engine removal considerations, (2) an aircraft systems layout, (3) a weapons integration model showing the internal weapons bay mechanism, (4) inlet and nozzle integration, (5) an aircraft suckdown prediction, (6) an aircraft stability and control analysis, including a takeoff, hover, and transition control analysis, (7) a performance and mission capability study, and (8) a life cycle cost analysis. A supersonic fighter aircraft with STOVL capability with the lift+lift/cruise engine cycle seems a viable option for the next generation fighter

    Physicians Infrequently Adhere to Hepatitis Vaccination Guidelines for Chronic Liver Disease

    Get PDF
    Background and Goals:Hepatitis A (HAV) and hepatitis B (HBV) vaccination in patients with chronic liver disease is an accepted standard of care. We determined HAV and HBV vaccination rates in a tertiary care referral hepatology clinic and the impact of electronic health record (EHR)-based reminders on adherence to vaccination guidelines.Methods:We reviewed the records of 705 patients with chronic liver disease referred to our liver clinic in 2008 with at least two follow-up visits during the subsequent year. Demographics, referral source, etiology, and hepatitis serology were recorded. We determined whether eligible patients were offered vaccination and whether patients received vaccination. Barriers to vaccination were determined by a follow-up telephone interview.Results:HAV and HBV serologic testing prior to referral and at the liver clinic were performed in 14.5% and 17.7%; and 76.7% and 74% patients, respectively. Hepatologists recommended vaccination for HAV in 63% and for HBV in 59.7% of eligible patients. Patient demographics or disease etiology did not influence recommendation rates. Significant variability was observed in vaccination recommendation amongst individual providers (30-98.6%), which did not correlate with the number of patients seen by each physician. Vaccination recommendation rates were not different for Medicare patients with hepatitis C infection for whom a vaccination reminder was automatically generated by the EHR. Most patients who failed to get vaccination after recommendation offered no specific reason for noncompliance; insurance was a barrier in a minority.Conclusions:Hepatitis vaccination rates were suboptimal even in an academic, sub-speciality setting, with wide-variability in provider adherence to vaccination guidelines. © 2013 Thudi et al

    Information for health futures research

    No full text
    corecore